Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
2.090
-0.060 (-2.79%)
Feb 27, 2026, 4:00 PM EST - Market closed
Clover Health Investments Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Premiums & Annuity Revenue | 1,892 | 1,345 | 1,243 | 1,178 | 688.79 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.98 | 0.01 | -4.71 | 8.95 | -0.05 | Upgrade
|
| Non-Insurance Activities Revenue | - | - | - | - | 667.64 | Upgrade
|
| Other Revenue | 30.8 | 25.77 | 24.75 | 11.95 | 5 | Upgrade
|
| Total Revenue | 1,924 | 1,371 | 1,263 | 1,199 | 1,361 | Upgrade
|
| Revenue Growth (YoY) | 40.33% | 8.52% | 5.32% | -11.91% | 97.30% | Upgrade
|
| Policy Benefits | 1,568 | 1,006 | 1,005 | 993.07 | 1,551 | Upgrade
|
| Depreciation & Amortization | 1.69 | 1.33 | 2.51 | 1.19 | 1.25 | Upgrade
|
| Selling, General & Administrative | 317.93 | 290.81 | 324.02 | 367.98 | 349.01 | Upgrade
|
| Other Operating Expenses | -0.8 | - | - | 0.07 | 0.19 | Upgrade
|
| Total Operating Expenses | 2,009 | 1,417 | 1,447 | 1,477 | 1,998 | Upgrade
|
| Operating Income | -85.53 | -45.93 | -184.29 | -277.45 | -636.99 | Upgrade
|
| Interest Expense | - | - | -0.01 | -1.36 | -16.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.05 | -0.09 | 0.9 | 66.15 | Upgrade
|
| EBT Excluding Unusual Items | -85.55 | -45.98 | -184.38 | -277.91 | -587.76 | Upgrade
|
| Merger & Restructuring Charges | - | -0.29 | -9.82 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | -11.7 | - | - | Upgrade
|
| Asset Writedown | - | - | -4.25 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 23.33 | - | Upgrade
|
| Pretax Income | -85.55 | -46.27 | -210.15 | -254.58 | -587.76 | Upgrade
|
| Earnings From Continuing Ops. | -85.55 | -46.27 | -210.15 | -254.58 | -587.76 | Upgrade
|
| Earnings From Discontinued Ops. | - | 3.26 | -3.21 | -84.98 | - | Upgrade
|
| Net Income | -85.55 | -43.01 | -213.36 | -339.57 | -587.76 | Upgrade
|
| Net Income to Common | -85.55 | -43.01 | -213.36 | -339.57 | -587.76 | Upgrade
|
| Shares Outstanding (Basic) | 512 | 490 | 482 | 476 | 413 | Upgrade
|
| Shares Outstanding (Diluted) | 512 | 490 | 482 | 476 | 413 | Upgrade
|
| Shares Change (YoY) | 4.48% | 1.63% | 1.25% | 15.33% | 365.57% | Upgrade
|
| EPS (Basic) | -0.17 | -0.09 | -0.44 | -0.71 | -1.42 | Upgrade
|
| EPS (Diluted) | -0.17 | -0.09 | -0.44 | -0.71 | -1.42 | Upgrade
|
| Free Cash Flow | -68.98 | 33.29 | -145.25 | -208.39 | -283.05 | Upgrade
|
| Free Cash Flow Per Share | -0.14 | 0.07 | -0.30 | -0.44 | -0.69 | Upgrade
|
| Operating Margin | -4.45% | -3.35% | -14.59% | -23.13% | -46.79% | Upgrade
|
| Profit Margin | -4.45% | -3.14% | -16.89% | -28.31% | -43.17% | Upgrade
|
| Free Cash Flow Margin | -3.59% | 2.43% | -11.50% | -17.38% | -20.79% | Upgrade
|
| EBITDA | -83.84 | -44.6 | -181.78 | -276.26 | -635.75 | Upgrade
|
| EBITDA Margin | -4.36% | -3.25% | -14.39% | -23.04% | -46.70% | Upgrade
|
| D&A For EBITDA | 1.69 | 1.33 | 2.51 | 1.19 | 1.25 | Upgrade
|
| EBIT | -85.53 | -45.93 | -184.29 | -277.45 | -636.99 | Upgrade
|
| EBIT Margin | -4.45% | -3.35% | -14.59% | -23.13% | -46.79% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.